Antiplatelet or anticoagulant therapy might not increase the risk of haemoptysis in patients with bronchiectasis

被引：0

作者：

Lee, J. ^{[1
]}

Park, Y. S. ^{[1
]}

Lee, C-H. ^{[1
]}

Lee, S-M. ^{[1
]}

Yoo, C-G. ^{[1
]}

Kim, Y. W. ^{[1
]}

Han, S. K. ^{[1
]}

Yim, J-J ^{[1
]}

机构：

[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 110744, South Korea

来源：

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2013年 / 17卷 / 07期

关键词：

bronchial artery embolisation; aspirin; warfarin; ASPIRIN;

D O I：

10.5588/ijtld.12.0807

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The aim of this study was to assess whether the use of antiplatelets and anticoagulants increased haemoptysis in patients with bronchiectasis. Cases (n = 242) with a history of haemoptysis were compared with controls (n = 242) without a history of haemoptysis. Of the 242 case patients, 16.5% took antiplatelets compared with 19.8% of controls (P = 0.346). The proportion of warfarin users did not differ between cases and controls (3.3% vs. 2.5%, P = 0.588). The use of these agents might not be associated with increased risk of haemoptysis in patients with bronchiectasis.

引用

页码：989 / 991

页数：3

共 50 条

[31] A Case of Failed Dual Antiplatelet Therapy With Oral Anticoagulant in the Prevention of Acute Ischemic Stroke
Amoda, Oluyemisi
Elmarie, A.
Uwagbale, Ese
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
[32] Role of Antiplatelet and Anticoagulant Therapy in Management of Peripheral Artery Disease
Park, Byung Joon
Hou, Linle
Galmer, Andrew
Johnston-Cox, Hillary
CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2023, 25 (09) : 379 - 390
[33] Effect of anticoagulant/antiplatelet therapy on the development and progression of diabetic retinopathy
Jeng, Chi-Juei
Hsieh, Yi-Ting
Lin, Cheng-Li
Wang, I-Jong
BMC OPHTHALMOLOGY, 2022, 22 (01)
[34] Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting An Open-Label, Randomized, Controlled Trial
Smits, Pieter C.
Frigoli, Enrico
Tijssen, Jan
Juni, Peter
Vranckx, Pascal
Ozaki, Yukio
Morice, Marie-Claude
Chevalier, Bernard
Onuma, Yoshinobu
Windecker, Stephan
Tonino, Pim A. L.
Roffi, Marco
Lesiak, Maciej
Mahfoud, Felix
Bartunek, Jozef
Hildick-Smith, David
Colombo, Antonio
Stankovic, Goran
Iniguez, Andres
Schultz, Carl
Kornowski, Ran
Ong, Paul J. L.
Alasnag, Mirvat
Rodriguez, Alfredo E.
Moschovitis, Aris
Laanmets, Peep
Heg, Dik
Valgimigli, Marco
CIRCULATION, 2021, 144 (15) : 1196 - 1211
[35] Prior antiplatelet or anticoagulant therapy and mortality in stroke
Kwok, Chun Shing
Skinner, Jane
Metcalf, Anthony K.
Potter, John F.
Myint, Phyo Kyaw
HEART, 2012, 98 (09) : 712 - 717
[36] Combined antiplatelet and novel oral anticoagulant therapy after acute coronary syndrome: is three a crowd?
Verheugt, Freek W. A.
EUROPEAN HEART JOURNAL, 2013, 34 (22) : 1618 - 1620
[37] Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease Focus on the COMPASS Trial
Gurbel, Paul A.
Fox, Keith A. A.
Tantry, Udaya S.
ten Cate, Hugo
Weitz, Jeffrey, I
CIRCULATION, 2019, 139 (18) : 2170 - 2185
[38] Oral Anticoagulant and Antiplatelet Therapy for Cervical Artery Dissection: A Meta-Analysis of Clinical Trials
Ye, Sheng-Lin
Wang, Chuang
Wang, Lu-Lu
Xu, Tian-Ze
Li, Xiao-Qiang
Tang, Tao
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27
[39] RISK AND BENEFIT OF COMBINED ANTIPLATELET AND ANTICOAGULANT THERAPIES
Marcucci, R.
Grifoni, E.
BLOOD TRANSFUSION, 2016, 14 : S653 - S657
[40] Characteristics and clinical outcomes of patients with acute gastrointestinal bleeding related to anticoagulant or antiplatelet therapy: a retrospective study
Bozic, Dorotea
Vukovic, Jonatan
Mustapic, Ivona
Cindro, Pavle Vrebalov
Bozic, Josko
Kardum, Goran
Puljiz, Zeljko
Hadjina, Ivana Tadin
Tonkic, Ante
CROATIAN MEDICAL JOURNAL, 2021, 62 (05) : 488 - 494

← 1 2 3 4 5 →